This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 103/11/1241    most recent CIRCRESAHA.108.178749v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by McKeown, C. R. Articles by Fowler, V. M. Search for Related Content PubMed PubMed Citation Articles by McKeown, C. R. Articles by Fowler, V. M. Related Collections Structure Cell biology/structural biology Developmental biology Genetically altered mice Other Vascular biology

(Circulation Research. 2008;103:1241.)
© 2008 American Heart Association, Inc.

Molecular Medicine

Tropomodulin1 Is Required in the Heart but Not the Yolk Sac for Mouse Embryonic Development

Caroline R. McKeown^*, Roberta B. Nowak^*, Jeannette Moyer, Mark A. Sussman, Velia M. Fowler

From the Scripps Research Institute (C.R.M., R.B.N., J.M., V.M.F.), Department of Cell Biology; and Department of Biology and San Diego State University Heart Institute (M.A.S.), San Diego State University, Calif.

Correspondence to Velia M. Fowler, The Scripps Research Institute, Department of Cell Biology, 10550 N Torrey Pines Rd, CB-163, La Jolla, CA 92037. E-mail velia{at}scripps.edu

Tropomodulin (Tmod)1 caps the pointed ends of actin filaments in sarcomeres of striated muscle myofibrils and in the erythrocyte membrane skeleton. Targeted deletion of mouse Tmod1 leads to defects in cardiac development, fragility of primitive erythroid cells, and an absence of yolk sac vasculogenesis, followed by embryonic lethality at embryonic day 9.5. The Tmod1-null embryonic hearts do not undergo looping morphogenesis and the cardiomyocytes fail to assemble striated myofibrils with regulated F-actin lengths. To test whether embryonic lethality of Tmod1 nulls results from defects in cardiac myofibrillogenesis and development or from erythroid cell fragility and subsequent defects in yolk sac vasculogenesis, we expressed Tmod1 specifically in the myocardium of the Tmod1-null mice under the control of the -myosin heavy chain promoter Tg(MHC-Tmod1). In contrast to Tmod1-null embryos, which fail to undergo cardiac looping and have defective yolk sac vasculogenesis, both cardiac and yolk sac morphology of Tmod1^{–/–Tg(MHC-Tmod1)} embryos are normal at embryonic day 9.5. Tmod1^{–/–Tg(MHC-Tmod1)} embryos develop into viable and fertile mice, indicating that expression of Tmod1 in the heart is sufficient to rescue the Tmod1-null embryonic defects. Thus, although loss of Tmod1 results in myriad defects and embryonic lethality, the Tmod1^–/– primary defect is in the myocardium. Moreover, Tmod1 is not required in erythrocytes for viability, nor do the Tmod1^–/– fragile primitive erythroid cells affect cardiac development, yolk sac vasculogenesis, or viability in the mouse.

Key Words: cardiac development • myofibrillogenesis • looping morphogenesis • yolk sac vasculogenesis • erythroid stability